NovaBay Pharmaceuticals (NBY) Q4 2024 Earnings

Nov 7Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-5.25
-3.6
-1.95
-0.3

Details

Expected EPS
-0.305
Actual EPS
-0.6
Surprise EPS
-0.3
Surprise Percent
-96.72%

Description

⁨NovaBay Pharmaceuticals⁩ (⁦NBY⁩) has reported earnings of ⁦-0.6⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts